" "
Any breastmilk production means the medication is contraindicated
Based on current phase 3 TRIUMPH trial timelines, a regulatory submission to the MHRA is not anticipated before 20262027 at the earliest, with a possible marketing authorisation in 20272028 and NHS availability potentially from 2028 onwards, subject to NICE appraisal
GLP-1 receptors exist in brain regions affected by Parkinson's, prompting clinical trials to explore whether these agents might slow disease progression or improve motor symptoms
At first, Wegovy was FDA-approved for chronic weight management when paired with exercise, dietary modifications, and increased physical activity in patients with obesity (body mass index 30 kg/m or more) and overweight (BMI 27 kg/m or more) with at least one weight-related health condition such as heart diseases, high blood pressure (hypertension), high cholesterol levels, type 2 diabetes, and sleep apnea
Use a small labeled container or shelf placement that makes your injection visible and memorable before each dose